AIBT 8-K
Aibotics, Inc. (AIBT)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 24, 2020
20/20 GLOBAL, INC. | ||||
(Exact name of registrant as specified in its charter) | ||||
|
|
|
|
|
Nevada |
| 000-56022 |
| 87-0645794 |
(State or other jurisdiction of |
| (Commission File Number) |
| (IRS Employer |
incorporation or organization) |
|
|
| Identification No.) |
|
|
|
|
|
480 22nd Street, Box 2 |
|
| ||
Heyburn, Idaho |
| 83336 | ||
(Address of principal executive offices) |
| (Zip code) | ||
|
|
| ||
Registrant’s telephone number, including area code: |
| Phone: (208) 312-7784 | ||
|
|
| ||
n/a | ||||
(Former name or former address, if changed since last report) | ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
|
| ||
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
|
| ||
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
|
| ||
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||
|
| ||
Securities to be registered pursuant to Section 12(b) of the Act: | |||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |
None | None | None | |
| |||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter). Emerging growth company [ ] | |||
| |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ] | |||
ITEM 1.01 – ENTRY INTO MATERIAL DEFINITIVE AGREEMENTS
On December 24, 2020, 20/20 Global, Inc. (“20/20 Global”) entered into definitive agreements with Ehave, Inc., an Ontario corporation (“Ehave”), Mycotopia Therapies Inc., a Florida corporation and wholly owned subsidiary of Ehave (“MYC”), and the former and current directors of 20/20 Global that provide for: (i) the change of control of 20/20 Global’s board of directors and management under a Change of Control and Funding Agreement; and (ii) 20/20 Global’s acquisition of MYC from Ehave under a Stock Purchase Agreement, resulting in MYC becoming a wholly owned subsidiary of 20/20 Global. In addition, Ehave also is purchasing control of 20/20 Global through a Stock Purchase Agreement with three of 20/20 Global’s principal stockholders. A closing of the transactions contemplated by the above documents is scheduled on January 4, 2021, through 20/20 Global’s transfer agent, Colonial Stock Transfer Company, Inc.
Ehave provides digital therapeutics and is the developer of KetaDASH, a home delivery platform for patients who have been prescribed Ketamine infusions. MYC offers therapy and wellness retreats focused on healing and understanding the causes and solutions to mental wellness through psychedelic enhanced psychotherapy, integrated with a team of mental wellness practitioners and cutting-edge technology.
ITEM 5.01 – CHANGES IN CONTROL OF REGISTRANT
On December 24, 2020, under a Stock Purchase Agreement with Mark D. Williams, Colin Gibson, and The Robert and Joanna Williams Trust, 20/20 Global’s principal stockholders, Ehave agreed to acquire approximately 75.77% of the issued and outstanding shares of 20/20 Global’s common stock for an aggregate $350,000. This transaction is also scheduled to close on January 4, 2021.
ITEM 5.02 - DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS
Under the above Change of Control and Funding Agreement, Mark D. Williams and Colin Gibson will resign as officers and directors and Benjamin Kaplan and Mark Croskery will be appointed to serve as replacement directors upon completion of all regulatory requirements. This agreement also provides for Mr. Kaplan to serve as president of 20/20 Global.
Benjamin Kaplan
Benjamin Kaplan, 51, has served as Ehave’s chief executive officer for the past 16 months and as chairman of its board of directors since June 2020. Mr. Kaplan has been an entrepreneur working for over 20 years in the financial sector. He has conducted his various investment activities out of New York City. Mr. Kaplan has invested in many companies both public and private, with a focus on international growth and potential for a global presence. In 2014, Mr. Kaplan was a founder and board member of Kaya Jamaica, Inc., a large cannabis company in the Caribbean (growkaya.com). In 2014, Mr. Kaplan invested in Surna (OTCQB: SRNA), a global HVAC company that provides engineering for and builds high technology facilities. In 2015, Mr. Kaplan invested in Kalytera (TSX: KALY), an Israeli botanical-based pharma company conducting research to determine cures for various illnesses, including a phase two trial for a cure for GVHD (graft versus host disease). In 2018, he assembled a 30,000 strong sales force in over 20 countries for Stemtech.com., a multi-level marketing company from south Florida. With a group of investors, they purchased the company out of bankruptcy, and Mr. Kaplan currently sits on the board of Stemtech. In 2018, Mr. Kaplan formed a partnership with others to invest in Sensi Magazine, which is published in several countries, to expand the botanical lifestyles of unique destinations globally.
2
Mark Croskery
Mark Croskery, 38, has 15 years of experience in financial services, wealth management, investment banking, and private equity in Jamaica and the Caribbean as a trusted advisor to many businesses and individuals. Mr. Croskery founded Croskery Capital Limited in September 2019, a boutique financial consulting company in Jamaica offering financial consulting and related services, and he currently serves as its chief executive officer and chairman of its board of directors. The company focuses on assisting corporations with strategy, building a board of directors, recruiting and aligning corporate executives (C-suite team), and troubleshooting financial accounting and operational business issues. From April 2018 to August 2019, Mr. Croskery was chief executive officer of SSL Growth Equity Limited (SSL Grow), Bridgetown, Barbados, which operated as an International Business Company in Barbados with most of its investments held in Jamaica and the Cayman Islands. At SSL Grow, Mr. Croskery was responsible for creating vision and strategy for the company’s equity, credit, and income initiatives. From May 2007 to March 2018, Mr. Croskery was president and chief executive officers of Stocks and Securities Ltd (“SSL”), Kingston, Jamaica, where he was responsible for the strategic direction and business development of the Investment Advisory Organization – Private Wealth Management, Financial Planning and Money Management, as a licensed securities dealer and member/ dealer. At SSL, Mr. Croskery provided leadership to the company’s operating team and led the sale of the company’s repurchase agreement book of business in November 2013, totaling in excess of J$ 2 billion in assets and liabilities. Mr. Croskery obtained a Master of Science degree in Global Financial Analysis, in June 2004, from Elkin B. Callum, Graduate School of Business, Bentley College, Waltham, MA, and a Bachelor of Science degree in Finance-Accounting in May 2003, from Bentley College, Waltham, MA.
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS
The following are filed as exhibits to this report:
Exhibit Number* |
|
Title of Document |
|
Location |
|
|
|
|
|
10.04 |
| Stock Purchase Agreement between 20/20 Global, Inc. and Ehave, Inc. |
| This filing |
|
|
|
|
|
10.05 |
|
| This filing |
_______________
*All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. Omitted numbers in the sequence refer to documents previously filed as an exhibit.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| 20/20 GLOBAL, INC. | |
|
|
|
Dated: December 29, 2020 | By: | /s/ Mark D. Williams |
|
| Mark D. Williams, President, |
|
| Chief Executive Officer |
3
STOCK PURCHASE AGREEMENT
THIS STOCK PURCHASE AGREEMENT (the “MYC SPA”) is made and becomes effective as of the date of last signature (the “Effective Date”), by and between 20/20 GLOBAL, INC., a Nevada corporation (“Purchaser”), and EHAVE INC., an Ontario corporation (“Seller”).
Premises
B.Seller owns beneficially and of record 100% of the issued and outstanding shares of capital stock of Mycotopia Therapies Inc., a Florida corporation (“MYC”).
C.On November 28, 2020, Purchaser, Seller, and MYC entered into a term sheet (the “Term Sheet”) outlining the terms and conditions of a reorganization transaction that includes: (i) Purchaser purchasing the MYC stock from Seller and MYC becoming a wholly owned subsidiary of Purchaser under the terms and conditions of this MYC SPA; (ii) Seller purchasing control of Purchaser from its principal stockholders under the terms and conditions of a separate stock purchase agreement (the “SPA”); and (iii) the change of control of Purchasers board of directors and management under the terms of change of control and funding agreement (the “Change of Control Agreement”).
D.The Term Sheet further provides that the closing of each of the transactions contemplated will be dependent on the closing of each of the other agreements and accordingly, the parties have agreed to enter into an escrow agreement with Purchaser’s stock transfer agent, Colonial Stock Transfer Company, Inc., to facilitate the simultaneous closing of the transactions outlined above (the “Escrow Agreement”).
E.The parties to this MYC SPA believe it is in their best interests and the best interests of their respective stockholders, as may be applicable, to enter into this MYC SPA, the SPA, the Change of Control Agreement, and the Escrow Agreement (together the, “Definitive Agreements”).
NOW, THEREFORE, on these premises, which are incorporated herein by reference, and in consideration of the mutual covenants and promises contained herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereby agree as follows:
1.Definition and Interpretations.
(a)Definitions. When used herein, the following terms will have the meanings set forth below.
(i)“Shares” means ONE MILLION (1,000,000) shares of common stock, no par value, of MYC, which constitute 100% of the issued and outstanding shares of capital stock of MYC.
(ii)“Purchase Price” means a total purchase price of three hundred and fifty thousand dollars and no cents ($350,000) for the Shares.
(iii)“Material Adverse Effect” means any effect or change that would be materially adverse to the business, assets, condition (financial or otherwise), operating
1
results, operations, or business prospects of either Purchaser or MYC, as the case may be, and its respective subsidiaries (if any), taken as a whole, or on the ability of any party to timely consummate the transactions contemplated by this MYC SPA.
(iv)“Person” means an individual, corporation, partnership, limited liability company, association, trust, unincorporated organization, entity, or group (as defined in Section 13(d) of the Exchange Act.
(v)“GAAP” means generally accepted accounting principles in the United States, as in effect on the date of determination, applied on a consistent basis.
(vi)“Governmental Entity” means any governmental or regulatory authority, agency, or instrumentality, domestic or foreign.
(b)Interpretation. The language in all parts of this MYC SPA will be, in all cases, construed simply according to its fair meaning and not strictly for or against any party. Section headings contained in this MYC SPA are for reference purposes only and will not affect the meaning or interpretation of this MYC SPA. Except when the context clearly requires to the contrary: (a) instances of gender or entity-specific usage (e.g., “his,” “her,” “its,” or “individual”) will not be interpreted to preclude the application of any provision of this MYC SPA to any individual or entity; (b) the word “or” will not be applied in its exclusive sense, unless the context otherwise requires; (c) “including” will mean that the items listed are illustrative and without limitation on the antecedent reference, without any implication that all or even most of the components are mentioned; (d) references to laws, regulations, and other governmental rules (collectively, “rules”), as well as to contracts, agreements, and other instruments (collectively, “instruments”), will mean such rules and instruments as in effect at the time of determination (taking into account any amendments thereto effective at such time without regard to whether such amendments were enacted or adopted after the effective date) and will include all successor rules and instruments thereto; (e) references to “$,” “cash,” or “dollars” will mean the lawful currency of the United States; (f) unless otherwise indicated, periods within which a payment is to be made or any other action is to be taken hereunder will be calculated excluding the day on which the period commences and including the day on which the period ends; (g) references to “federal” will be to laws, agencies, or other attributes of the United States (and not to any state or locality thereof); (h) if any day specified in this MYC SPA for any notice, action, or event is not a business day, then the due date for such notice, action, or event will be extended to the next succeeding business day; (i) references to “days” will mean calendar days; references to “business days” will mean all days other than Saturdays, Sundays, and days that are legal holidays in the state of Nevada; and (j) days, business days, and times of day will be determined by reference to local time in Nevada.
2.Sale of Shares. At the Closing (as hereinafter defined), Purchaser will purchase the Shares for the Purchase Price. In consideration for the Purchase Price, Seller will issue and deliver certificates or a written statement pursuant to Fla. Stat. § 607.0626 representing the Shares to the Escrow Agent.
3.Representations and Warranties of Seller. As an inducement to the execution of this MYC SPA by Purchaser and to the fulfillment of the provisions hereof to be performed by Purchaser, Seller covenants, represents, and warrants to Purchaser that:
(a)Authority; Enforceability. Seller has full legal capacity, power, and authority to enter into and perform this MYC SPA and the other documents to be executed and delivered by Seller in connection with this MYC SPA, and this MYC SPA and the other Definitive Agreements constitute the valid and legally binding obligations of Seller, enforceable in accordance with their respective terms.
2
(b)Title. Seller is the registered holder of, and the owner of good title to, all of the Shares to be sold by Seller hereunder, free and clear of any liens, claims, charges, encumbrances, equities, or options whatsoever. The Shares may be validly assigned, transferred, and delivered by Seller as herein provided.
(c)Organization, Qualification, and Good Standing. MYC is a corporation duly organized, validly existing, and in good standing under the laws of the state of Florida and has the corporate power and authority to own all of its properties and assets, to carry on its business in all material respects as it is now being conducted, and to perform its obligations pursuant to its certificate of incorporation and bylaws. There is no jurisdiction in which MYC is not so qualified in which the character and location of the assets owned by it or the nature of the business transacted by it requires qualification, except where failure to do so would not have a Material Adverse Effect on the business or properties of MYC.
(d)Capitalization. MYC has one class of equity securities capital stock and ownership interests. MYC is authorized to issue 10,000,000 shares of capital stock, of which 1,000,000 shares are issued and outstanding. The Shares constitute 100% of the issued and outstanding capital stock of MYC as issued to Seller, and no shares of equity securities are reserved for issuance on the exercise of any other call, commitment, right, or other contractual arrangements to which MYC is a party or by which it is bound. All issued and outstanding shares of MYC’s equity securities are duly authorized, validly issued, fully paid, and nonassessable and were not issued in violation of (nor are any of the authorized shares of MYC’s equity securities subject to) any preemptive or similar rights created by statute, MYC’s certificate of incorporation or bylaws, or any agreement to which MYC is a party or bound. There are no obligations, contingent or otherwise, of MYC to: (i) repurchase, redeem, or otherwise acquire any shares of MYC’s equity securities; or (ii) provide material funds to, make any material investment in (in the form of a loan, advance, financial accommodation, capital contribution, or otherwise), or provide a guarantee respecting the obligations of any other Person. There are no agreements, arrangements, or commitments of any character (contingent or otherwise) pursuant to which any Person is or may be entitled to receive any payment based on the revenues or earnings or calculated in accordance therewith of MYC. There are no voting trusts, proxies, or other agreements or understanding to which MYC is party, by which MYC is bound, or of which it has knowledge respecting the voting of any shares of capital stock or ownership interest of MYC. There are no options, warrants, convertible securities, calls, or other rights (including securities rights), agreements, arrangements, or commitments of any character to which MYC is a party or by which it is bound relating to the issued or unissued equity securities of MYC.
(e)Financial Information. The books and records, financial and otherwise, of MYC are in all material respects complete and correct and have been made and maintained in accordance with sound business and bookkeeping practices and, in reasonable detail, accurately and fairly reflect the transactions involving the assets of MYC. MYC has maintained a system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions have been and are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary to permit the preparation of financial statements in conformity with GAAP and any other criteria applicable to such statements and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals, and appropriate action is taken for any differences.
(f)Intellectual Property. MYC does not own or use: (i) trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, and proprietary rights and processes; or (ii) patents and patent rights in the conduct of MYC’s business as now conducted and as
3
presently proposed to be conducted, other than commercially available software products under standard end-user object code license agreements. MYC has not received any communications alleging that it has violated or by conducting its business would violate any of the patents, trademarks, service marks, trade names, copyrights, trade secrets, or other proprietary rights or processes of any other Person.
(g)No Conflict with Other Instruments. The consummation of the transactions contemplated herein will not result in the breach of any term or provision of, or constitute an event of default under, any material indenture, mortgage, deed of trust, or other material contract, agreement, or instrument to which MYC is a party or to which any of its properties or operations are subject, that would have a Material Adverse Effect on MYC.
(h)Legal Matters. Neither MYC nor any Person associated with MYC has received notice of any threatened Legal Matter, and MYC is not subject to any consent decree, settlement, or other similar written agreement, or continuing order of or investigation by, any Governmental Entity or any judgment, order, writ, injunction, decree, or award of any Governmental Entity or arbitrator, including cease-and-desist or other orders, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, hearing, or any other actual, threatened, or completed proceeding, or known claim, inquiry, examination, or investigation, whether civil, criminal, administrative, or investigative, at law or in equity (each, a “Legal Matter”), against MYC or any Person affiliated or associated with MYC or to which MYC’s operations or property is subject. Neither MYC nor any affiliated associated Person with MYC has received notice of any threatened Legal Matter.
(i)Governmental Authorizations. MYC has all licenses, franchises, permits, and other governmental authorizations that are legally required to enable it to conduct its business in all material respects as conducted on the Effective Date or as presently contemplated. No authorization, approval, consent, or order of, or registration, declaration, or filing with, any court or other Governmental Entity is required in connection with the consummation of the transactions contemplated herein.
(j)Third-Party Consents. Except as set forth in this MYC SPA and the other Definitive Agreements, no contract, agreement, lease, or other commitment, written or oral, to which MYC is a party or to which any of its properties or assets are subject requires the consent of the other party in order to consummate the transactions herein contemplated.
(k)Compliance with Laws and Regulations. MYC has complied with all applicable statutes and regulations of any federal, state, or other Governmental Entity thereof, except to the extent that noncompliance would not have a Material Adverse Effect on the business, operations, properties, assets, or financial condition of MYC or except to the extent that noncompliance would not result in the incurrence of any material liability for MYC.
(l)Full Disclosure. No representation or warranty by MYC in this MYC SPA, the other Definitive Agreements, or in any document or schedule to be delivered by MYC pursuant hereto, and no written statement, certificate, or instrument furnished or to be furnished to Purchaser pursuant hereto or in connection with the negotiation, execution, or performance of this MYC SPA contains, or will contain, any untrue statement of a material fact or omits, or will omit, to state any fact necessary to make any statement herein or therein not materially misleading or necessary to a complete and correct presentation of all material aspects of the businesses of MYC.
4
4.Representations and Warranties of Purchaser. As an inducement to the execution of this MYC SPA by Seller and to the fulfillment of the provisions hereof to be performed by Seller, Purchaser covenants, represents, and warrants to Purchaser that:
(a)20/20 Global is a corporation duly organized, validly existing, and in good standing under the laws of the state of Nevada and has the corporate power and authority to own all of its properties and assets, to carry on its business in all material respects as it is now being conducted, and to perform its obligations pursuant to its articles of incorporation and bylaws.
(b)20/20 Global has all necessary corporate power and authority to execute this MYC SPA and perform its obligations hereunder. This MYC SPA constitutes the valid and binding obligation of 20/20 Global, enforceable against it in accordance with its terms, except as may be limited by bankruptcy, moratorium, insolvency, or other similar laws generally affecting the enforcement of creditors’ rights.
(c)The execution and delivery of this MYC SPA does not, and the consummation of the transactions contemplated by this MYC SPA in accordance with the terms hereof will not:
(i)violate any provision of 20/20 Global’s articles of incorporation or bylaws;
(ii)violate, conflict with, result in the breach of any of the terms of, result in a material modification of, otherwise give any other contracting party the right to terminate, or constitute (or with notice or lapse of time or both constitute) a default under, any contract or other agreement to which 20/20 Global is a party or by or to which it or any of its assets or properties may be bound or subject;
(iii)violate any order, judgment, injunction, award, or decree of any court, arbitrator, or governmental entity against or binding upon 20/20 Global or its properties or business; or
(iv)violate any statute, law, or regulation of any jurisdiction applicable to the transactions contemplated herein, which could have a Material Adverse Effect on the business or operations of 20/20 Global.
(d)The execution of this MYC SPA and the consummation of the transactions contemplated by this MYC SPA will not result in the breach of any term or provision of, or constitute an event of default under, any material indenture, mortgage, deed of trust, or other material contract, agreement, or instrument to which 20/20 Global is a party or to which any of its properties or operations are subject and would have a Material Adverse Effect on 20/20 Global.
(e)20/20 Global has complied with all applicable statutes and regulations of any federal, state, or other governmental entity, except to the extent that noncompliance would not have a Material Adverse Effect on the business, operations, properties, assets, or financial condition of 20/20 Global or except to the extent that noncompliance would not result in the incurrence of any material liability for 20/20.
(f)20/20 Global has filed or furnished (as applicable) all forms, reports, and documents with the U.S. Securities and Exchange Commission (“SEC”) that have been required to be so filed or furnished (as applicable) by it under applicable law, together with all certifications required pursuant to the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”), prior to the Effective Date (the “SEC Reports”). Each SEC Report complied, as of its filing date, as to form, in all material respects with the applicable requirements of the Sarbanes-Oxley Act, the
5
Securities Act of 1933, as amended, or the Exchange Act, and the applicable rules and regulations of the SEC thereunder, as the case may be, each as in effect on the date such SEC Report was filed. True, correct, and complete copies of all SEC Reports filed prior to the Effective Date, whether or not required under applicable law, are publicly available in the Electronic Data Gathering, Analysis and Retrieval (EDGAR) database of the SEC. As of its filing date, each SEC Report did not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. As of the Effective Date, there are no outstanding or unresolved comments in comment letters received from the SEC with respect to the SEC Reports. To 20/20 Global’s knowledge, none of the SEC Reports is the subject of ongoing SEC review and there are no inquiries or investigations by the SEC or any internal investigations pending or threatened, in each case regarding any accounting practices of 20/20 Global. None of 20/20 Global’s subsidiaries is required to file any forms, reports, or other documents with the SEC. No executive officer of 20/20 Global has failed to make the certifications required of him under Section 302 or 906 of the Sarbanes-Oxley Act with respect to any SEC Report.
(g)The consolidated financial statements of 20/20 Global filed in or furnished with the SEC Reports have been prepared in accordance with GAAP consistently applied by 20/20 Global during the periods and at the dates involved (except as may be indicated in the notes thereto or as permitted by Regulation S-X, or in the case of unaudited financial statements, as permitted by Form 10-Q or any successor form under the Exchange Act), and fairly present in all material respects the consolidated financial position of 20/20 Global as of the dates thereof and the consolidated results of operations and cash flows for the periods referred to therein (subject, in the case of the unaudited financial statements, to normal and recurring year-end adjustments that are not, individually or in the aggregate, material).
(h)Since the date of the Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, there has not been any Material Adverse Effect on the business or operations of 20/20 Global, and no Material Adverse Effect is expected.
5.Closing.
(a)Closing. The consummation of the transactions contemplated by the Definitive Agreements (the “Closing”) will take place through an escrow account maintained by the Escrow Agent in accordance with the terms and conditions of the Escrow Agreement on or before January 4, 2021, or at such other date as Seller and Purchaser may agree (“Closing Date”). At the Closing, all transactions contemplated by the Definitive Agreements will be conducted substantially concurrently and no transaction will be deemed to be completed until all are completed.
(b)Deliveries by Purchaser. At the Closing, Purchaser will deliver to Purchase Price to the Escrow Agent.
(c)Deliveries by Seller. At the Closing, Seller will deliver certificates or a written statement pursuant to Fla. Stat. § 607.0626 representing the Shares to the Escrow Agent.
(d)Termination of Lease. Purchaser will terminate its lease with Whistling Pete Enterprises, d/b/a Legacy Center, an Idaho limited liability company.
6.Survival. All representations, warranties, covenants, and agreements contained in this MYC SPA or in any document delivered pursuant hereto will survive the Closing for a period of two years and will be fully effective and enforceable following the Closing Date.
6
7.General Provisions.
(a)Amendment and Waiver. No amendment or waiver of any provision of this MYC SPA will be valid unless the same is in writing and signed by all parties.
(b)Notices. Any notice, demand, request, or other communication permitted or required under this MYC SPA will be in writing and will be deemed to have been given as of the date so delivered, if personally delivered; as of the date so sent, if sent by electronic mail and receipt is acknowledged by the recipient; and one day after the date so sent, if delivered by overnight courier service; addressed as follows:
(i)If to Seller:
Ehave Inc.
Attn: Benjamin Kaplan
18851 NE 29th Ave. Suite 700
Aventura, FL 33180
Email: [email protected]
With copy to:
Jonathan D. Leinwand, P.A.
Attn: Jonathan D. Leinwand
1885 1 NE 29th Ave, Suite 1011
Aventura, FL 33180
Email: [email protected]
(ii)If to Purchaser:
20/20 Global, Inc.
Attn: Mark D. Williams
622 South 45 Lane West
Rupert, ID 83350
Email: Mark@20/20Global.com
With copy to:
Michael Best & Friedrich LLP
Attn: Terrell W. Smith
170 South Main Street, Suite 1000
Salt Lake City, Utah 84101
Email: [email protected]
Notwithstanding the foregoing, service of legal process or other similar communications will not be given by electronic mail and will not be deemed duly given under this MYC SPA if delivered by such means. Each party, by notice duly given in accordance herewith, may specify a different address for the giving of any notice hereunder.
(c)Successors and Assigns. No party will assign its rights, duties, and obligations under this MYC SPA without the written consent of the other parties, except as otherwise specifically contemplated in this MYC SPA. This MYC SPA will be binding upon, inure to the benefit of, and be enforceable by the parties and their permitted successors and assigns.
7
(d)Entire Agreement. This MYC SPA incorporates and includes all prior negotiations, correspondence, conversations, agreements, or understandings applicable to the matters contained herein, and the parties agree that there are no commitments, agreements, or understandings concerning the subject matter of this MYC SPA that are not contained in the Definitive Agreements. The parties acknowledge that, in deciding to enter into this MYC SPA, they have not relied upon any statements, promises, or representations, written or oral, express or implied, other than those set forth in the Definitive Agreements. Accordingly, it is agreed that no deviation from the terms hereof will be predicated upon any prior representations or agreements, whether oral or written. The parties acknowledge that they have negotiated this MYC SPA at arm’s-length with adequate representation on an equal basis.
(e)Governing Law. This MYC SPA will be governed by and construed under and in accordance with the laws of the state of Nevada without giving effect to any choice or conflict of law provision or rule (whether the state of Nevada or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the state of Nevada.
(f)Counterpart Signatures. This MYC SPA may be executed in multiple counterparts of like tenor, each of which will be deemed an original but all of which taken together will constitute one and the same instrument. Counterpart signatures of this MYC SPA that are manually signed and delivered by facsimile transmission; by a uniquely, marked computer-generated signature; or by other electronic methods, will be deemed to constitute signed original counterparts hereof and will bind the parties signing and delivering in such manner and will be the same as the delivery of an original.
(g)Incorporated Documents. All appendices, attachments, and other documents to be delivered by the parties hereto at or prior to the Closing Date are hereby incorporated in this MYC SPA by this reference.
IN WITNESS WHEREOF, the parties hereto have duly executed this MYC SPA as of the dates written above.
PURCHASER: | ||
|
|
|
20/20 GLOBAL, INC. | ||
|
|
|
|
|
|
By: | /s/ Mark D. Williams | |
| Mark D. Williams, President | |
| Date: | 12/24/20 |
|
|
|
|
|
|
SELLER: |
| |
|
|
|
EHAVE INC. | ||
|
|
|
|
|
|
By: | /s/ Benjamin Kaplan | |
| Benjamin Kaplan, President | |
| Date: | 12/23/20 |
8
CHANGE OF CONTROL AND FUNDING AGREEMENT
THIS CHANGE OF CONTROL AND FUNDING AGREEMENT (this “Change of Control Agreement”), effective as of the date of the last signature (the “Effective Date”), is made by and among 20/20 GLOBAL, INC., a Nevada corporation (“20/20 Global”), EHAVE INC., an Ontario corporation (“Ehave”), MYCOTOPIA THERAPIES INC., a Florida corporation (“MYC”), MARK D. WILLIAMS, COLIN GIBSON, BENJAMIN KAPLAN, and MARK CROSKERY.
Premises
A.20/20 Global is a publicly traded, fully reporting company that is current in its periodic reporting requirements under the Securities Exchange Act of 1934, as amended. 20/20 Global ceased active business operations in January 2020.
B.Mark D. Williams and Colin Gibson are directors and Mark D. Williams is the president and Karen Johnson is the Secretary/Treasurer of 20/20 Global.
C.Benjamin Kaplan is president of Ehave and MYC.
D.On November 28, 2020, 20/20 Global, Ehave, and MYC entered into a term sheet (the “Term Sheet”) outlining the terms and conditions of a reorganization transaction that includes: (i) the change of control of 20/20 Global’s board of directors and management under the terms of this Change of Control Agreement; (ii) Ehave purchasing control of 20/20 Global from its principal stockholders under the terms and conditions of a Stock Purchase Agreement (“SPA”); and (iii) 20/20 Global acquiring MYC from Ehave under a separate stock purchase agreement (the “MYC SPA”) resulting in MYC becoming a wholly owned subsidiary of 20/20 Global.
E.The Term Sheet further provides that the closing of each of the transactions contemplated will be dependent on the closing of each of the other agreements and accordingly, the parties have agreed to enter into an escrow agreement with 20/20 Global’s stock transfer agent, Colonial Stock Transfer Company, Inc., to facilitate the simultaneous closing of the transactions outlined above (the “Escrow Agreement”).
F.The parties believe it is in their best interests and the best interests of their respective stockholders, as may be applicable, to enter into this Change of Control Agreement, the SPA, the MYC SPA, and the Escrow Agreement (together, the “Definitive Agreements”) and agree to close the transactions contemplated by the Definitive Agreements on January 4, 2021.
Agreement
NOW, THEREFORE, based on these premises, which are incorporated herein by reference, and in consideration of the mutual covenants and promises contained herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereby agree as follows:
1.Agreements Relating to Board Composition and Officer Positions.
(a)Mark D. Williams and Colin Gibson hereby resign, seriatim in the order listed, and appoint Benjamin Kaplan and Mark Croskery to serve as members of 20/20 Global board of directors (“New Board”), as of the execution and delivery of this Change of Control Agreement by all signatories. The appointment of the New Board will be delayed and will become effective
automatically on 20/20 Global’s compliance with Rule 14f-1 under the Securities Exchange Act, which the New Board will cause 20/20 Global to complete as promptly as practical, with the mailing of the required notice commencing in no event later than January 18, 2021.
(b)Mark D. Williams hereby resigns as president, chief executive officer, and chief financial officer, and Karen Johnson hereby resigns as secretary/treasurer, and the New Board hereby appoints Benjamin Kaplan to serve as president. As soon as practical after the Effective Date, the New Board will enter into employment agreements with each of the new executive officers.
2.Representations and Warranties of 20/20 Global. As an inducement to the execution of this Change of Control Agreement by Ehave, MYC, and Benjamin Kaplan and to the fulfillment of the provisions hereof to be performed by Ehave and MYC, 20/20 Global covenants, represents, and warrants to Ehave, MYC, and Benjamin Kaplan that except as set forth in the other Definitive Agreements:
(a)There are no other agreements or proposed transactions between 20/20 Global and any of its officers, directors, or stockholders or any affiliate of any officer, director, or stockholder.
(b)There are no amounts due to the officers and directors of 20/20 Global.
3.Additional Agreements of Existing Board of Directors. Commencing on the Effective Date and prior to the closing of the Definitive Agreements, the existing board of directors will cause 20/20 Global: (a) to terminate its investment retirement account; (b) to introduce the New Board to its auditor Pinnacle Accountancy Group of Utah and its accountant Rachel Boulds; and (c) to deliver its EDGAR credentials to the New Board.
4.Additional Agreements of the New Board. Commencing on the Effective Date and as soon as practical, the New Board and executive officers will cause:
(a)20/20 Global to use its commercially reasonable efforts to raise $5 million to expand the psilocybin business of MYC through a Regulation A offering or other such offering as the New Board may determine.
(b)20/20 Global to continue discussions with Dr. Rita Marley relating to her wellness centers in Jamaica.
(c)20/20 Global to comply with the terms and conditions of this Change of Control Agreement.
5.Indemnification. The existing board of directors agrees to indemnify members of the New Board, jointly and severally, and hold each one of them harmless from and against any and all claims, liabilities, losses, damages, and expenses incurred by the New Board, including fees of counsel as they are incurred, in connection with investigating, preparing for, or defending any action, formal or informal claim, investigation, inquiry, or other proceeding, whether or not in connection with pending or threatened litigation, caused by or arising out of or in connection with the New Board acting pursuant to this Change of Control Agreement, whether or not any member of the New Board is named as a party thereto and whether or not any liability results therefrom. The existing board will not, however, be responsible for any claims, liabilities, loses, damages, or expenses pursuant to this section that are finally judicially determined to have resulted primarily from the New Board’s bad faith or gross negligence. The New Board further agrees that it will not, without existing board’s prior written consent, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action, suit, or proceeding for which
2
indemnification may be sought hereunder (whether or not the New Board is an actual or potential party to such claim, action, suit, or proceeding) unless the settlement, compromise, or consent includes an unconditional release of both the existing board and the New Board thereunder from all liability arising out of such claim, action, suit, or proceeding.
6.Miscellaneous.
(a)This Change of Control Agreement and the covenants and conditions contained herein will be binding upon the parties and applied to and be binding upon their respective subsidiaries, assignees, licensees, sublicensees, transferees, principals, partners, limited partners, affiliates, officers, directors, stockholders, members, managers, employees, servants, parents, heirs, predecessors, successors, agents, insurance carriers, attorneys, and representatives.
(b)The parties participated jointly in the preparation of this Change of Control Agreement. Each party to this Change of Control Agreement has had the opportunity to draft, review, comment upon, and revise this Change of Control Agreement. It is agreed that no rule of construction will apply against a party or in favor of a party. This Change of Control Agreement will be construed as if the parties jointly prepared this Change of Control Agreement and any uncertainty or ambiguity will not be interpreted against one party.
(c)The parties acknowledge that they have been represented by counsel of their own choice in the negotiations leading to their execution of this Change of Control Agreement, and they have read and understood this Change of Control Agreement and have had it fully explained to them by their counsel.
(d)The parties agree that this Change of Control Agreement is executed and delivered, and is intended to be performed, in the state of Nevada and the substantive laws of such state, excluding the principles of conflicts of laws, will govern the validity, construction, enforcement, and interpretation of this Change of Control Agreement except insofar as federal laws will have application.
(e)The provisions of this Change of Control Agreement are severable and should any provision hereof be void, voidable, or unenforceable under any applicable law, such void, voidable, or unenforceable provision will not affect or invalidate any other provision of this Change of Control Agreement, which will continue to govern the relative rights and duties of the parties as though the void, voidable, or unenforceable provision was not a part hereof. In addition, it is the intention and agreement of the parties that all of the terms and conditions hereof be enforced to the fullest extent permitted by law.
(f)This Change of Control Agreement may be executed in any number of counterparts (and any counterpart may be executed by original, portable document format (pdf), or facsimile signature), each of which when executed and delivered will be deemed an original, but all of which will constitute one and the same instrument.
(g)If a legal action or other proceeding is brought for enforcement of this Change of Control Agreement because of an alleged dispute, breach, or misrepresentation in connection with any of the provisions hereof, the successful or prevailing party will be entitled to recover reasonable attorney’s fees and costs incurred, both before and after judgment, in addition to any other relief to which they may be entitled.
3
(h)The signatories to this Change of Control Agreement agree that as long as they have material nonpublic information about 20/20 Global, they will not use it to trade in 20/20 Global securities and that to the extent that they continue to serve as directors of 20/20 Global, they owe a fiduciary duty to the company to refrain from improper disclosure of confidential information.
IN WITNESS WHEREOF, the parties have executed this Change of Control Agreement as of the Effective Date.
4